PL2119452T3 - Kompozycja farmaceutyczna zawierająca przeciwciało monoklonalne anty-cd6 do zastosowania w diagnostyce i leczeniu reumatoidalnego zapalenia stawów - Google Patents

Kompozycja farmaceutyczna zawierająca przeciwciało monoklonalne anty-cd6 do zastosowania w diagnostyce i leczeniu reumatoidalnego zapalenia stawów

Info

Publication number
PL2119452T3
PL2119452T3 PL07855983T PL07855983T PL2119452T3 PL 2119452 T3 PL2119452 T3 PL 2119452T3 PL 07855983 T PL07855983 T PL 07855983T PL 07855983 T PL07855983 T PL 07855983T PL 2119452 T3 PL2119452 T3 PL 2119452T3
Authority
PL
Poland
Prior art keywords
diagnosis
treatment
pharmaceutical composition
monoclonal antibody
rheumatoid arthritis
Prior art date
Application number
PL07855983T
Other languages
English (en)
Inventor
José Enrique MONTERO CASIMIRO
Ángel Raimundo CASACO PARADA
Zaima Mazorra Herrera
Ruby Alonso Ramirez
Rolando Perez Rodriguez
Original Assignee
Centro De Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Inmunologia Molecular filed Critical Centro De Inmunologia Molecular
Publication of PL2119452T3 publication Critical patent/PL2119452T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL07855983T 2006-12-26 2007-12-24 Kompozycja farmaceutyczna zawierająca przeciwciało monoklonalne anty-cd6 do zastosowania w diagnostyce i leczeniu reumatoidalnego zapalenia stawów PL2119452T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU20060250 2006-12-26
EP07855983.8A EP2119452B1 (en) 2006-12-26 2007-12-24 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis
PCT/CU2007/000021 WO2008077355A1 (es) 2006-12-26 2007-12-24 Composición farmaceutica que comprende un anticuerpo monoclonal anti-cd6 utilizado en el diagnóstico y tratamiento de la artritis reumatoide

Publications (1)

Publication Number Publication Date
PL2119452T3 true PL2119452T3 (pl) 2021-03-08

Family

ID=39562112

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07855983T PL2119452T3 (pl) 2006-12-26 2007-12-24 Kompozycja farmaceutyczna zawierająca przeciwciało monoklonalne anty-cd6 do zastosowania w diagnostyce i leczeniu reumatoidalnego zapalenia stawów

Country Status (19)

Country Link
US (3) US20100092423A1 (pl)
EP (1) EP2119452B1 (pl)
KR (1) KR101482956B1 (pl)
CN (2) CN105251004A (pl)
AR (1) AR064527A1 (pl)
AU (1) AU2007336563B2 (pl)
CA (1) CA2676185C (pl)
DK (1) DK2119452T3 (pl)
ES (1) ES2785043T3 (pl)
HK (1) HK1213782A1 (pl)
IT (1) ITTO20070942A1 (pl)
MY (1) MY165625A (pl)
NZ (1) NZ578635A (pl)
PE (1) PE20081553A1 (pl)
PL (1) PL2119452T3 (pl)
PT (1) PT2119452T (pl)
RU (1) RU2472526C2 (pl)
UY (1) UY30838A1 (pl)
WO (1) WO2008077355A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587632A (en) 2008-03-14 2012-06-29 Biocon Ltd An anti-cd6 monoclonal antibody and a method thereof
EP2371863A1 (en) * 2010-03-30 2011-10-05 Pierre Fabre Médicament Humanized anti CXCR4 antibodies for the treatment of cancer
US11037196B2 (en) 2012-02-24 2021-06-15 Netclearance Systems, Inc. Interactive advertising using proximity events
US11062258B2 (en) 2012-02-24 2021-07-13 Netclearance Systems, Inc. Automated logistics management using proximity events
KR102405247B1 (ko) 2013-07-23 2022-06-07 바이오콘 리미티드 Cd6 결합 파트너의 용도 및 이에 기초한 방법
WO2016145961A1 (zh) * 2015-03-13 2016-09-22 江苏恒瑞医药股份有限公司 抗硬骨素抗体、其抗原结合片段及其医药用途
CN108883151A (zh) * 2016-02-10 2018-11-23 开曼化学股份有限公司 抗瓜氨酸化hla多肽抗体以及其用途
PL3529274T3 (pl) 2016-10-21 2024-09-09 Biocon Limited Przeciwciało monoklonalne i sposób jego stosowania w leczeniu tocznia
US11334889B2 (en) 2016-11-29 2022-05-17 Netclearance Systems, Inc. Mobile ticketing based on proximity
US11151534B2 (en) * 2016-11-29 2021-10-19 Netclearance Systems, Inc. Consumer interaction module for point-of-sale (POS) systems
CN109903854B (zh) * 2019-01-25 2023-04-07 电子科技大学 一种基于中医药文献的核心药物识别方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US699755A (en) 1902-03-06 1902-05-13 Ira G Hoag Train-order box in connection with semaphores.
US6162432A (en) * 1991-10-07 2000-12-19 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
EP0631783A1 (en) * 1993-06-03 1995-01-04 Mitsubishi Chemical Corporation Antiviral combinations of 2',3'-di-deoxyribonucleosides with 6-benzyl-1-ethoxymethyl-5-substituted uracil derivatives
EP0726912A4 (en) * 1993-11-02 2000-08-23 Univ Duke Cd6 ligand
US5423562A (en) * 1993-11-05 1995-06-13 Pearce, Jr.; Fredric C. Chair lift
CU22615A1 (es) * 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
CU22584A1 (es) * 1995-11-17 1999-11-03 Centro Inmunologia Molecular Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
DE69707843T2 (de) * 1996-03-20 2002-05-16 Aventis Pharma S.A., Antony TRIZYCLISCHE VERBINDUNGEN MIT WIRKUNG AUF INTEGRINE, BESONDERS AUF DAS ALPHAvBETA3-INTEGRIN, VERFAHREN ZUR IHRER HERSTELLUNG UND ZWISCHENPRODUKTE DES VERFAHRENS, IHRE VERWENDUNG ALS ARZNEIMITTEL UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
CA2282410A1 (en) * 1997-03-03 1998-10-01 Bristol-Myers Squibb Company Monoclonal antibodies to human cd6
ATE311199T1 (de) * 1999-05-07 2005-12-15 Genentech Inc Behandlung von autoimmunkrankheiten mit antagonisten die oberflächenmarker von b zellen binden
FI110553B (fi) * 2001-02-12 2003-02-14 Perlos Oyj Liitin ja liittimen irtopala
ES2192128B1 (es) * 2001-04-27 2005-01-01 Universidad De Vigo Anticuerpo monoclonal humano que reconoce especificamente la molecula humana cd69, y su uso en terapia.
CN101031305A (zh) * 2004-09-29 2007-09-05 兴和株式会社 类风湿性关节炎的预防和/或治疗药物
BRPI0517837A (pt) * 2004-11-12 2008-10-21 Xencor Inc variantes fc com ligação alterada a fcrn
CN101111521B (zh) * 2004-12-29 2011-08-24 株式会社柳韩洋行 肿瘤坏死因子-α特异性人源化抗体

Also Published As

Publication number Publication date
AR064527A1 (es) 2009-04-08
RU2009128659A (ru) 2011-02-10
DK2119452T3 (da) 2020-04-20
CN101657215A (zh) 2010-02-24
UY30838A1 (es) 2008-07-31
CA2676185A1 (en) 2008-07-03
KR20090122910A (ko) 2009-12-01
CA2676185C (en) 2013-03-12
MY165625A (en) 2018-04-18
US20160024220A1 (en) 2016-01-28
RU2472526C2 (ru) 2013-01-20
AU2007336563A1 (en) 2008-07-03
EP2119452A4 (en) 2012-06-06
US20170066835A1 (en) 2017-03-09
EP2119452A1 (en) 2009-11-18
CN105251004A (zh) 2016-01-20
WO2008077355A1 (es) 2008-07-03
KR101482956B1 (ko) 2015-01-15
PE20081553A1 (es) 2008-12-10
EP2119452B1 (en) 2020-03-04
ITTO20070942A1 (it) 2008-06-27
ES2785043T3 (es) 2020-10-05
US20100092423A1 (en) 2010-04-15
AU2007336563B2 (en) 2012-11-01
HK1213782A1 (zh) 2016-07-15
NZ578635A (en) 2012-03-30
PT2119452T (pt) 2020-05-08

Similar Documents

Publication Publication Date Title
PT2119452T (pt) Composição farmacêutica que compreende um anticorpo monoclonal anti-cd6 utilizado no diagnóstico e tratamento de artrite reumatoide
IL212633A (en) A monoclonal antibody or its antigen-binding portion, its pharmaceutical preparations and its use in the preparation of cancer drugs
PL1765314T3 (pl) Zestaw składników farmaceutycznych do leczenia choroby i objawów reumatoidalnego zapalenia stawów
IL205948A0 (en) 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
IL199216A (en) Monoclonal Antibodies Against 3angptl, Pharmaceuticals Containing Them and Their Uses
IL196550A0 (en) Anti-il-6 monoclonal antibodies and uses thereof
IL197831A0 (en) Human antibodies that bind cxcr4 and uses thereof
IL200610A0 (en) Human monoclonal anti-ip-10 antibodies and uses thereof
IL219268A (en) Anti-b79cd antibody, immunosuppressant and pharmacological agent that includes and uses it
IL214779A (en) Isolated monoclonal antibody or epitope-binding antibody on cadm1, methods of preparation and use for drug preparation
IL199045A0 (en) Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
IL197148A (en) Antibodies and preparations for the treatment of antibodies caused by antibodies
EP1998799A4 (en) HUMANIZED ANTIBODIES AGAINST CD22 ANTIGEN AND THEIR USE FOR THERAPEUTIC USE IN ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASES
IL186659A0 (en) Il-31 monoclonal antibodies and methods of use
IL197914A0 (en) Diagnosis and treatment of cancer using anti-ereg antibody
PL2594586T3 (pl) Przeciwciała monoklonalne IL-31 i sposoby ich zastosowania
IL193444A (en) Isolated reactive monoclonal antibody that binds both IL-17a and IL-17f, an isolated serum containing it, a diagnostic kit containing it, a pharmaceutical product containing it, and its use as a drug to treat or prevent inflammation or inflammatory disease.
HUE046564T2 (hu) XI-es faktor elleni monoklonális antitestek és eljárások az alkalmazásukra
EP1999148A4 (en) HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN ONCOLOGY TREATMENT, TRANSPLANTATION AND AUTOIMMUNE DISEASE
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
WO2009135861A3 (en) Humanized antibodies against human interferon-alpha
PL2128253T3 (pl) Przeciwciało anty-FGF23 i kompozycja zawierająca takie przeciwciało
EP2077325A4 (en) MONOCLONAL ANTIBODY AND ITS USE
WO2007103468A3 (en) Use of vx-702 for treating rheumatoid arthritis
PH12013500432A1 (en) Anti-vegfr-3 antibody compositions